Shivalik Rasayan Ltd

Shivalik Rasayan Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Shivalik Rasayan Ltd

₹ 536 -1.04%
04 Jul - close price
shivalikrasayan.com BSE: 539148 NSE: SHIVALIK
About

Incorporated in 1979, Shivalik Rasayan Ltd is a manufacturer of Agrochemicals & Active Pharma Ingredients[1]

Key Points

Business Overview:[1]
SRL is the largest Indian producer of Dimethoate Technical and second largest Indian producer of Malathion Technical. It also manufactures organophosphorus-based insecticides and chemicals. Apart from this, company does development of Oncology and Non-Oncology active pharmaceutical ingredients and their finished dosage forms

Website BSE NSE
  • Market Cap ₹ 844 Cr.
  • Current Price ₹ 536
  • High / Low ₹ 879 / 500
  • Stock P/E 50.6
  • Book Value ₹ 340
  • Dividend Yield 0.09 %
  • ROCE 5.40 %
  • ROE 3.20 %
  • Face Value ₹ 5.00
Edit ratios

Pros

Cons

  • Promoter holding has decreased over last quarter: -0.58%
  • The company has delivered a poor sales growth of 10.8% over past five years.
  • Tax rate seems low
  • Company has a low return on equity of 3.75% over last 3 years.
  • Dividend payout has been low at 4.77% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals

Part of BSE SmallCap BSE Allcap BSE Commodities

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
48.14 57.83 56.33 57.36 62.93 64.47 67.05 70.23 71.23 74.63 82.44 85.31 69.39
37.84 45.99 45.32 47.38 52.81 53.10 57.39 61.37 61.94 65.25 70.68 71.99 63.63
Operating Profit 10.30 11.84 11.01 9.98 10.12 11.37 9.66 8.86 9.29 9.38 11.76 13.32 5.76
OPM % 21.40% 20.47% 19.55% 17.40% 16.08% 17.64% 14.41% 12.62% 13.04% 12.57% 14.26% 15.61% 8.30%
1.85 1.45 0.85 1.46 0.90 0.42 0.56 1.50 1.49 0.64 0.35 1.60 5.71
Interest 0.89 1.03 0.88 1.07 1.36 1.47 1.96 1.58 2.61 1.92 2.45 2.26 2.71
Depreciation 2.85 3.01 2.83 2.95 2.81 2.81 3.44 3.01 3.11 3.50 4.66 4.84 2.78
Profit before tax 8.41 9.25 8.15 7.42 6.85 7.51 4.82 5.77 5.06 4.60 5.00 7.82 5.98
Tax % 3.09% 8.54% 6.26% 10.24% -3.21% 13.72% 45.02% 24.78% 9.09% 16.09% 11.60% 11.38% 13.21%
8.14 8.46 7.65 6.65 7.08 6.48 2.65 4.34 4.60 3.86 4.43 6.94 5.19
EPS in Rs 4.51 4.40 3.82 3.27 2.28 2.80 1.21 1.97 2.21 2.26 2.58 3.39 2.62
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
41 110 123 155 171 186 198 215 234 273 312
38 99 105 131 147 157 159 167 191 232 272
Operating Profit 3 10 18 24 24 29 38 47 43 41 40
OPM % 7% 9% 15% 16% 14% 16% 19% 22% 19% 15% 13%
0 1 1 3 8 3 1 4 5 4 8
Interest 0 5 6 4 3 2 2 3 5 9 9
Depreciation 0 2 2 2 3 4 9 11 12 12 16
Profit before tax 3 5 11 20 26 27 29 37 32 23 23
Tax % 33% 33% 25% 25% 20% 17% 15% 7% 6% 22% 13%
2 3 8 15 21 22 25 34 30 18 20
EPS in Rs 2.10 3.66 9.84 14.39 9.88 10.17 12.77 17.68 14.32 8.17 10.60
Dividend Payout % 0% 0% 4% 3% 5% 2% 4% 3% 3% 6% 5%
Compounded Sales Growth
10 Years: 22%
5 Years: 11%
3 Years: 13%
TTM: 14%
Compounded Profit Growth
10 Years: 25%
5 Years: 4%
3 Years: -13%
TTM: 31%
Stock Price CAGR
10 Years: 45%
5 Years: 14%
3 Years: -10%
1 Year: -26%
Return on Equity
10 Years: 7%
5 Years: 5%
3 Years: 4%
Last Year: 3%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 3 3 3 4 7 7 7 7 7 8 8
Reserves 8 11 7 45 158 169 172 280 412 500 528
0 31 32 22 20 10 29 38 58 76 94
11 36 52 81 103 142 155 163 101 109 104
Total Liabilities 23 81 94 152 288 328 363 488 578 692 734
7 27 27 40 41 52 210 221 218 214 336
CWIP 0 0 0 0 26 102 0 3 57 117 0
Investments 0 0 0 0 0 0 0 0 0 0 0
16 53 66 111 222 175 153 264 303 362 398
Total Assets 23 81 94 152 288 328 363 488 578 692 734

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
4 12 8 -7 -8 6 59 11 -19 -8 -8
-0 -18 -4 -24 -24 -102 -65 -23 -71 -74 -13
1 3 -3 52 100 10 2 78 50 89 10
Net Cash Flow 4 -3 2 21 69 -86 -4 66 -40 7 -10

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 80 77 92 108 111 114 127 119 132 116 113
Inventory Days 5 64 76 65 71 65 34 148 239 266 268
Days Payable 126 152 137 103 123 171 152 216 208 136 151
Cash Conversion Cycle -41 -11 31 71 59 7 9 51 162 245 230
Working Capital Days -11 36 52 107 147 160 98 146 206 200 221
ROCE % 32% 32% 28% 16% 11% 11% 12% 8% 6% 5%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
50.32% 50.32% 50.32% 50.32% 50.05% 47.95% 47.95% 47.95% 47.95% 47.95% 47.95% 47.37%
0.04% 0.01% 0.01% 0.01% 0.35% 0.66% 1.18% 2.99% 2.15% 3.28% 4.33% 4.28%
0.00% 0.00% 0.00% 0.00% 0.00% 0.24% 0.59% 0.88% 0.88% 0.88% 0.88% 0.64%
49.64% 49.67% 49.67% 49.67% 49.60% 51.14% 50.28% 48.17% 49.00% 47.87% 46.81% 47.72%
No. of Shareholders 7,7268,3808,5798,4608,5569,1909,1499,39810,00110,62711,63312,841

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls

  • Nov 2024
    Transcript
    Notes
    PPT
  • Dec 2021
    Transcript
    Notes
    PPT
  • Sep 2021
    Transcript
    Notes
    PPT
  • Aug 2020
    Transcript
    Notes
    PPT
  • Dec 2019
    Transcript
    Notes
    PPT
  • Dec 2019
    Transcript
    Notes
    PPT